Company / Total Assets
Alaunos Therapeutics, Inc. Total Assets History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.0M
FY2025
5-year range
$2.8M / $94.9M
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 4 years of decline, reaching $3M.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -54.1%.
Declined from $8M to $3M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -64.3%
- 5-Year CAGR
- -54.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -54.1%, indicating a declining trend.
- In FY2025, total assets increased 7.7% year-over-year.
- Peak total assets was recorded in FY2020.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0M | +7.7% |
| FY2024 | $2.8M | -66.7% |
| FY2023 | $8.3M | -87.3% |
| FY2022 | $64.9M | -31.5% |
| FY2021 | $94.9M | -35.2% |
| FY2020 | $146.3M | +34.1% |
| FY2019 | $109.1M | +14.8% |
| FY2018 | $95.1M | +32.5% |
| FY2013 | $71.8M | -14.0% |
| FY2012 | $83.4M | -22.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026